Investigation of mechanisms and regulatory pathways of p27kip expression in macrophages and the role of p27kip in the pathogenesis of atherosclerosis
Project/Area Number |
15K19519
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Metabolomics
|
Research Institution | Kumamoto University |
Principal Investigator |
Ishii Norio 熊本大学, 医学部附属病院, 特任助教 (10599111)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 動脈硬化 / 脂質代謝異常 / マクロファージ / 細胞周期 |
Outline of Final Research Achievements |
As for the pathophysiological significance of the macrophage proliferation in the atherosclerosis, there are still many questions left to be answered. To verify the direct evidence of involvement of local macrophage proliferation for atherosclerosis, we generated transgenic mice received p27kip expression only in the macrophages(mac-p27Tg), whose macrophage proliferation was specifically inhibited. The aortic valve annulus section average plaque area was significantly reduced in mac-p27Tg, compared with that of the control. The percentage of the necrotic core to the total advanced lesion area significantly decreased in mac-p27Tg. The inflammatory cytokines were also reduced in mac-p27Tg. We found that the local macrophage proliferation could be one of the common underlying pathophysiological features in the formation and the progression of atherosclerosis. Our results might lead to the control of the macrophage proliferation as the therapeutic target for atherosclerotic disease.
|
Report
(3 results)
Research Products
(11 results)
-
[Journal Article] Acetate alters expression of genes involved in beige adipogenesis in 3T3-L1 cells and obese KK-Ay mice2016
Author(s)
Hanatani S, Motoshima H, Takaki Y, Kawasaki S, Igata M, Matsumura T, Kondo T, Senokuchi T, Ishii N, Kawashima J, Kukidome D, Shimoda S, Nishikawa T, Araki E
-
Journal Title
Journal of Clinical Biochemistry and Nutrition
Volume: 59
Issue: 3
Pages: 207-214
DOI
NAID
ISSN
0912-0009, 1880-5086
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy.2015
Author(s)
Shimoda S, Okubo M, Koga K, Sekigami T, Kawashima J, Kukidome D, Igata M, Ishii N, Shimakawa A, Matsumura T, Motoshima H, Furukawa N, Nishida K, Araki E
-
Journal Title
Endocr J
Volume: 62
Pages: 209-216
NAID
Related Report
Peer Reviewed
-
[Journal Article] Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation.2015
Author(s)
Fukuda K, Matsumura T, Senokuchi T, Ishii N, Kinoshita H, Yamada S, Murakami S, Nakao S, Motoshima H, Kondo T, Kukidome D, Kawasaki S, Kawada T, Nishikawa T, Araki E
-
Journal Title
Biochem Biophys Res Commun
Volume: 457
Pages: 23-30
Related Report
Peer Reviewed
-
-
-
-
-
[Presentation] Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, suppresses the progression of atherosclerosis in diabetic apoE-deficient mice.2016
Author(s)
Murakami S, Matsumura T, Senokuchi T, Ishii N, Fukuda K, Yamada S, Morita Y, Nishida S, Sato M, Motoshima H, Kondo T, Araki E
Organizer
The 8th AASD Scientific Meeting
Place of Presentation
Taipei International Convention Center, Taipei, Taiwan
Year and Date
2016-10-27
Related Report
Int'l Joint Research
-
[Presentation] ストレプトゾトシン誘発糖尿病apoE欠損マウスにおいてエンパクリフロジンは大血管症進展を抑制する.2016
Author(s)
村上彩子, 松村剛, 瀬ノ口隆文, 石井規夫, 福田一起, 山田沙理恵, 守田雄太郎, 西田周平, 久木留大介, 本島寛之, 近藤龍也, 荒木栄一
Organizer
第31回日本糖尿病合併症学会
Place of Presentation
宮城
Year and Date
2016-10-07
Related Report
-
-